Risk factor burden drives adverse outcomes in gene-negative hypertrophic cardiomyopathy
The findings indicate that standard treatment thresholds may be insufficient, and more intensive risk-factor management is warranted in HCMG- patients, and that standard treatment thresholds may be insufficient.